Alagebrium: Phase IIb data

In the double-blind, placebo-controlled, U.S. Phase IIb SAPPHIRE/SILVER trial, alagebrium reduced

Read the full 118 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE